This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Astrazeneca Pharmaceuticals LP. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Emily Bosco: Innovator in Pharmaceutical Research
Introduction
Emily Bosco is a dedicated inventor and researcher based in the United States. She has made significant contributions to the field of pharmaceutical research, particularly in the development of small molecule inhibitors. Her work focuses on targeting specific protein interactions that are crucial for various biological processes.
Latest Patents
Emily Bosco currently holds no patents. However, her notable work includes the invention titled "Use Of Small Molecule Inhibitors Targeting The Interaction Between Rac Gtpase And P67(phox)." This invention provides inhibitors of the p67phox protein, along with pharmaceutical compositions and methods related to their use.
Career Highlights
Emily is affiliated with the Children's Hospital Medical Center, where she applies her expertise in pharmaceutical research. Her role at this esteemed institution allows her to contribute to innovative solutions in healthcare and medicine.
Collaborations
Emily collaborates with talented colleagues, including Yi Zheng and Prakash Jagtap. These partnerships enhance her research efforts and foster a collaborative environment for innovation.
Conclusion
Emily Bosco is an emerging inventor in the pharmaceutical field, with a focus on developing inhibitors that target critical protein interactions. Her work at the Children's Hospital Medical Center showcases her commitment to advancing medical research and improving patient outcomes.